212.44
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$214.05
Offen:
$213.13
24-Stunden-Volumen:
719.54K
Relative Volume:
0.42
Marktkapitalisierung:
$50.00B
Einnahmen:
$244.67B
Nettoeinkommen (Verlust:
$1.68B
KGV:
30.57
EPS:
6.9487
Netto-Cashflow:
$5.51B
1W Leistung:
+2.94%
1M Leistung:
-2.48%
6M Leistung:
+36.85%
1J Leistung:
+63.83%
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CAH
Cardinal Health Inc
|
212.46 | 50.37B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
MCK
Mckesson Corporation
|
859.18 | 108.31B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
321.83 | 63.18B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
HSIC
Henry Schein Inc
|
75.00 | 8.48B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
2.16 | 1.90B | 14.85M | -136.07M | 7.23M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health, Inc. (CAH) stock price, news, quote and history - Yahoo Finance UK
Longtime supervisor sues Cardinal Health over age and gender bias - hcamag.com
Cardinal Health, Inc. (CAH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cardinal Health ER Laceration Tray ACS-SLAC1 | Health Supply 770 INC - primetimes.id
Cardinal Health (NYSE:CAH) Upgraded at Wall Street Zen - MarketBeat
Global Clinical Drainage Supplies Market Dominated by North America as Cardinal Health and Medline Expand Products - WFMZ.com
Wells Fargo raises outlook on Cardinal Health (CAH), cites broad business strength - MSN
Tema Etfs LLC Trims Cardinal Health Stock Position - National Today
Tema Etfs LLC Decreases Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Inc (CLH.SG) stock price, news, quote and history - Yahoo Finance UK
Cardinal Health Increases Ac-225 Production to Enhance Cancer Treatment Options - Bitget
Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies - Yahoo Finance
HF Advisory Group LLC Buys 5,049 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Kwmg LLC Has $16.51 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts - Yahoo Finance
Cardinal Health, Shine Technologies amp up domestic production of radiopharmaceuticals - Healthcare Brew
Cardinal Health (CAH) Boosts Actinium-225 Production for Future Therapies - gurufocus.com
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth? - The Globe and Mail
Cardinal Health (CAH) Boosts Actinium-225 Production Capacity - gurufocus.com
Insiders At Cardinal Health Sold US$53m In Stock, Alluding To Potential Weakness - Yahoo Finance
Nisa Investment Advisors LLC Trims Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cancer drug developers get more Actinium-225 as Cardinal Health expands - Stock Titan
List of 30 Acquisitions by Cardinal Health (Apr 2026) - tracxn.com
Can CAH’s Unique Specialty Flywheel Approach Drive Sustainable Growth Over Time? - Bitget
Cardinal Health, Inc. (NYSE:CAH) Short Interest Up 21.1% in March - MarketBeat
Did Cardinal Health's (CAH) New Chair and Urology Deal Just Reframe Its Healthcare Partnership Strategy? - Sahm
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance Singapore
Cardinal Health Inc. stock rises Tuesday, still underperforms market - marketwatch.com
3 Dividend Stocks With High Returns on Invested Capital - Investing.com
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years - Sahm
Cardinal Health, Inc. $CAH Shares Sold by Wedge Capital Management L L P NC - MarketBeat
-0.54% for Cardinal Health stock as price stays below key moving averages - Traders Union
Jim Cramer on Cardinal Health: "I want you to buy it and buy it, get this, aggressively" - MSN
Jim Cramer on Cardinal Health: “I Want You to Buy It and Buy It, Get This, Aggressively” - Insider Monkey
UBS reiterates Buy on Cardinal Health stock, $260 price target - Investing.com
Global X Japan Co. Ltd. Increases Position in Cardinal Health, Inc. $CAH - MarketBeat
Bethlehem - dailyvoice.com
Cardinal Health (CAH) Stock Moves -1.71%: What You Should Know - Yahoo Finance
Why The Narrative Around Cardinal Health (CAH) Is Shifting With New Targets And Guidance - Yahoo Finance
Cardinal Health Inc. stock outperforms competitors despite losses on the day - marketwatch.com
Vanguard (CAH) parent reports zero CAH holdings after realignment - Stock Titan
Cardinal Health (CAH) Appoints New Chair as Gregory Kenny Steps Down - insidermonkey.com
Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says - Infectious Disease Advisor
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Cardinal Health Inc. stock faces steady trading amid distribution sector pressures and healthcare su - AD HOC NEWS
Cardinal Health appoints Patricia Hemingway Hall board chair - drugstorenews.com
Cardinal Health (CAH) Emerged as a Key Contributor on Pharmaceutical Strength and Margin Expansion - Yahoo Finance
Pensionfund Sabic Invests $1.79 Million in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Names New Chair As Valuation And Momentum Diverge - Sahm
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30 - Sahm
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):